Cetrorelix and Ganirelix Flexible Protocol for (IVF)
Launched by UNIVERSITÀ DEGLI STUDI 'G. D'ANNUNZIO' CHIETI E PESCARA · Mar 19, 2018
Trial Information
Current as of June 03, 2025
Unknown status
Keywords
ClinConnect Summary
No description provided
Gender
FEMALE
Eligibility criteria
- Inclusion criteria :
- • 18-39 hyears old with regular menstrual cycles (25-35 days in length);
- • Body Mass Index between 18-29 kg\\m2
- • Basal follicle-stimulating hormone levels within normal range (\<30 mUI\\mL)
- • Absence of clinically relevant anomalies at transvaginal ultrasound examinatio
- Exclusion Criteria:
- • Patients affected by grade III or IV endometriosis according to American Society for Reproductive Medicine (ASRM)
- • History of Ovarian Hyperstimulation Stimulation (OHSS)
- • History of poor response in previous IVF\\ICSI cycle: ≤ 3 oocytes retrieved
- • ≥ 3 prior consecutive IVF\\ICSI cycle without a clinical pregnancy.
About Università Degli Studi 'G. D'annunzio' Chieti E Pescara
The Università degli Studi 'G. D'Annunzio' Chieti e Pescara is a prestigious academic institution in Italy, renowned for its commitment to advancing medical research and education. With a strong emphasis on interdisciplinary collaboration, the university actively engages in clinical trials that aim to enhance patient care and therapeutic outcomes. Its dedicated research teams leverage cutting-edge methodologies and innovative approaches to address pressing health challenges, contributing significantly to the scientific community and the development of novel medical interventions. Through its robust infrastructure and expertise, the university fosters an environment conducive to excellence in clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ortona, Chieti, Italy
Patients applied
Trial Officials
Gian Mario Tiboni, professor
Study Director
Università degli Studi 'G. d'Annunzio' Chieti e Pescara
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials